Gujarat Themis Biosyn Set to Acquire MicroBiopharm Japan for ₹1,300 Crore
Strategic Expansion in the Pharmaceutical Sector Gujarat Themis Biosyn Ltd, a prominent Indian pharmaceutical manufacturer, announced a definitive agreement this week to acquire the Japanese biotechnology firm MicroBiopharm Japan Co. Ltd for ₹1,300 crore. The acquisition, finalized amidst a period of robust growth for the Indian firm, marks a significant cross-border expansion aimed at bolstering…